Michael Koenigsmann

6.1k total citations
63 papers, 1.5k citations indexed

About

Michael Koenigsmann is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Michael Koenigsmann has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 18 papers in Oncology and 15 papers in Immunology. Recurrent topics in Michael Koenigsmann's work include Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Michael Koenigsmann is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (12 papers) and Hematopoietic Stem Cell Transplantation (9 papers). Michael Koenigsmann collaborates with scholars based in Germany, United States and Austria. Michael Koenigsmann's co-authors include Kathleen Jentsch‐Ullrich, Martin Mohren, Andreas Franke, J DiCarlo, Astrid Franke, M.U. Heim, JD Griffin, G Lutze, Enrico Schalk and A. Franke and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Koenigsmann

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Koenigsmann Germany 20 436 405 296 290 227 63 1.5k
Silvia Park South Korea 21 581 1.3× 650 1.6× 218 0.7× 206 0.7× 299 1.3× 163 1.5k
João L. Ascensão United States 21 529 1.2× 599 1.5× 282 1.0× 164 0.6× 334 1.5× 65 1.8k
Sanna Siitonen Finland 23 354 0.8× 226 0.6× 324 1.1× 229 0.8× 427 1.9× 51 1.4k
Manfred Mitterer Italy 21 526 1.2× 293 0.7× 279 0.9× 110 0.4× 284 1.3× 58 1.3k
Jacques Tébib France 25 272 0.6× 386 1.0× 669 2.3× 158 0.5× 402 1.8× 91 2.3k
B Andersson United States 20 478 1.1× 616 1.5× 327 1.1× 214 0.7× 211 0.9× 39 1.5k
Andreas Trojan Switzerland 22 741 1.7× 151 0.4× 567 1.9× 295 1.0× 339 1.5× 64 1.8k
N Philippe France 18 220 0.5× 456 1.1× 327 1.1× 154 0.5× 255 1.1× 59 1.4k
Kurt W. Tauer United States 15 1.1k 2.4× 373 0.9× 745 2.5× 270 0.9× 200 0.9× 31 1.8k
Lawrence Schwartz United States 18 446 1.0× 225 0.6× 153 0.5× 512 1.8× 431 1.9× 39 1.6k

Countries citing papers authored by Michael Koenigsmann

Since Specialization
Citations

This map shows the geographic impact of Michael Koenigsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Koenigsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Koenigsmann more than expected).

Fields of papers citing papers by Michael Koenigsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Koenigsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Koenigsmann. The network helps show where Michael Koenigsmann may publish in the future.

Co-authorship network of co-authors of Michael Koenigsmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Koenigsmann. A scholar is included among the top collaborators of Michael Koenigsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Koenigsmann. Michael Koenigsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koenigsmann, Michael, et al.. (2023). Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR. Journal of Clinical Medicine. 12(20). 6569–6569. 2 indexed citations
2.
Koschmieder, Steffen, Susanne Isfort, Clemens Schulte, et al.. (2023). Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial. Annals of Hematology. 102(12). 3383–3399. 6 indexed citations
3.
Lutz, Manfred P., N. Ansorge, Christoph Burkart, et al.. (2023). 1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216). Annals of Oncology. 34. S899–S900. 1 indexed citations
4.
5.
Al-Batran, S-E., Wael Hozaeel, Ralf‐Dieter Hofheinz, et al.. (2015). The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax). Annals of Oncology. 26(6). 1244–1248. 46 indexed citations
6.
Atmaca, Akin, S-E. Al-Batran, Dominique Werner, et al.. (2013). A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer. British Journal of Cancer. 108(2). 265–270. 27 indexed citations
7.
Koehler, Michael, Michael Koenigsmann, & Jörg Frommer. (2008). Coping with illness and subjective theories of illness in adult patients with haematological malignancies: Systematic review. Critical Reviews in Oncology/Hematology. 69(3). 237–257. 32 indexed citations
8.
Beuing, Oliver, et al.. (2008). Paraneoplastische Limbische Enzephalitis als Erstmanifestation eines malignen Non Hodgkin Lymphoms. Fortschritte der Neurologie · Psychiatrie. 76(1). 41–46. 8 indexed citations
9.
10.
11.
Schalk, Enrico, Martin Mohren, Kathleen Jentsch‐Ullrich, et al.. (2006). Zygomycoses in patients with acute leukaemia. Annals of Hematology. 85(5). 327–32. 10 indexed citations
12.
Mohren, Martin, et al.. (2006). Increased risk of venous thromboembolism in patients with acute leukaemia. British Journal of Cancer. 94(2). 200–202. 54 indexed citations
13.
Koenigsmann, Michael, et al.. (2005). Subjektive Krankheitsvorstellungen bei Patienten mit akuter Leukämie eine Woche nach Diagnosestellung/ Illness Perceptions of Patients Suffering from Acute Leukaemia One Week after Diagnosis. Zeitschrift für psychosomatische Medizin und Psychotherapie. 51(4). 388–402. 4 indexed citations
14.
Jentsch‐Ullrich, Kathleen, Michael Koenigsmann, Martin Mohren, & Andreas Franke. (2005). Lymphocyte subsets' reference ranges in an age- and gender-balanced population of 100 healthy adults—A monocentric German study. Clinical Immunology. 116(2). 192–197. 131 indexed citations
15.
Schalk, Enrico, Martin Mohren, Michael Koenigsmann, et al.. (2005). Metastatic Adrenal Neuroblastoma in an Adult. Oncology Research and Treatment. 28(6-7). 353–355. 7 indexed citations
16.
Koenigsmann, Michael, Martin Mohren, Kathleen Jentsch‐Ullrich, et al.. (2004). High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation. Bone Marrow Transplantation. 34(6). 477–483. 18 indexed citations
17.
Klemke, Claus‐Detlev, Edgar Dippel, Christoph C. Geilen, et al.. (2003). Atypical generalized eruptive histiocytosis associated with acute monocytic leukemia. Journal of the American Academy of Dermatology. 49(5). 233–236. 17 indexed citations
18.
Röcken, Christoph, et al.. (2002). Pulmonary low-grade MALT-lymphoma associated with localized pulmonary amyloidosis. A case report. Amyloid. 9(3). 190–193. 14 indexed citations
19.
Papadimitriou, Christos, et al.. (1995). Immunomagnetic Selection of CD34+ Cells from Fresh Peripheral Blood Mononuclear Cell Preparations Using Two Different Separation Techniques. Journal of Hematotherapy. 4(6). 539–544. 17 indexed citations
20.
Hiddemann, Wolfgang, M. Zühlsdorf, B. Wörmann, Michael Koenigsmann, & Thomas Büchner. (1990). Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy—A case report on the basis of a clinical phase II trial. Leukemia Research. 14(4). 347–352. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Park Breakdown of academic impact, for papers by João L. Ascensão Breakdown of academic impact, for papers by Sanna Siitonen Breakdown of academic impact, for papers by Manfred Mitterer Breakdown of academic impact, for papers by Jacques Tébib Breakdown of academic impact, for papers by B Andersson Breakdown of academic impact, for papers by Andreas Trojan Breakdown of academic impact, for papers by N Philippe Breakdown of academic impact, for papers by Kurt W. Tauer Breakdown of academic impact, for papers by Lawrence Schwartz
Rankless by CCL
2026